Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccine development for syphilis.

Karen V Lithgow1, Caroline E Cameron1

  • 1a Department of Biochemistry and Microbiology , University of Victoria , Victoria , Canada.

Expert Review of Vaccines
|June 22, 2016
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancements in Syphilis Vaccine Development.

Sexually transmitted diseases·2026
Same author

Growing together: reflections on Canada's first interdisciplinary women's health research training program.

Humanities & social sciences communications·2026
Same author

Deep Learning-Based Structure Modeling of the <i>Treponema pallidum</i> Proteome: Insights into Pathogenesis and Syphilis Vaccine Development.

bioRxiv : the preprint server for biology·2026
Same author

<i>Treponema pallidum</i> induces pro-inflammatory cytokine secretion in macrophages and macrophage-endothelial co-cultures.

Frontiers in cellular and infection microbiology·2025
Same author

Time-course transcriptomics reveals the impact of <i>Treponema pallidum</i> on microvascular endothelial cell function and phenotype.

Frontiers in microbiology·2025
Same author

Time-course Transcriptomics Reveals the Impact of <i>Treponema pallidum</i> on Microvascular Endothelial Cell Function and Phenotype.

bioRxiv : the preprint server for biology·2025

Developing a syphilis vaccine is crucial for global health, complementing existing prevention and treatment strategies. This approach aims to control the spread of syphilis caused by Treponema pallidum.

Area of Science:

  • Infectious Diseases
  • Vaccinology
  • Microbiology

Background:

  • Syphilis, caused by Treponema pallidum subspecies pallidum, remains a significant global health concern.
  • Current penicillin treatment is effective, but a vaccine is needed to complement public health efforts.
  • The development of a syphilis vaccine is a viable preventative strategy to reduce worldwide disease spread.

Purpose of the Study:

  • To highlight the urgent need for a syphilis vaccine.
  • To review past syphilis vaccine research and identify key infection targets.
  • To outline the correlates of protection necessary for successful vaccination.

Main Methods:

  • Review of existing literature on syphilis vaccine development.
  • Analysis of Treponema pallidum infection characteristics relevant to vaccination.
Keywords:
HIV co-infectionSyphiliscellular immunitycongenital syphiliscross-protectionhumoral immunitymen who have sex with menvaccine

Related Experiment Videos

  • Synthesis of current understanding of protective immunity against syphilis.

    • Main Results:

    • Syphilis vaccine development is a priority for industry, regulatory, and funding bodies.
    • Prior studies provide valuable insights into potential vaccine targets and strategies.
    • Understanding correlates of protection is essential for guiding vaccine design.

    Conclusions:

    • A syphilis vaccine is a critical component in the global strategy to combat syphilis.
    • Continued research and investment are necessary to advance syphilis vaccine development.
    • A two-pronged approach combining vaccination with existing public health measures will be most effective.